Chadi Nabhan, MD, MBA, FACP
Chadhi Nabhan, MD, MBA, FACP, is a hematologist/oncologist and award-winning host of the “Outspoken Oncology” and “Healthcare Unfiltered” podcasts.
Articles by Chadi Nabhan, MD, MBA, FACP
We saw patients [who] were going to die, and it saved their life and then it's gone and it's shocking," she explained.
Dr. Cortes chats about the “boom” in treatments for chronic myeloid leukemia (CML), and where he sees a need for balance.
Elias Jabbour, MD, discusses the most burning questions in acute lymphoblastic leukemia (ALL).
Dr. Fonseca offers his thoughts on the future of multiple myeloma treatment and more.
Dr. de Lima discusses progress and remaining challenges with allogeneic CAR-T and other cellular therapy products.
Swaminathan Iyer, MD, joins Chadi Nabhan, MD, MBA, FACP, to discuss advances in T-cell lymphoma.
Joseph Khoury, MD; Sanam Loghavi, MD; and Chadi Nabhan, MD, MBA, FACP, discuss the MDS classification systems.
Jonathan Friedberg, MD, MMSc, discusses the trial and its implications for the field.
Dr. Garcia-Manero discusses key data from the phase III COMMANDS trial.
The crew talk about AML and MDS in this episode of The HemOnc Pulse.
Dr. Erba answers this question and more in this interview with Dr. Chadi Nabhan.
Dr. Nath spoke transplant in patients with AML who are elderly and emphasized the need to include them in clinical trials.
Dr. Platzbecker joins Chadi Nabhan, MD, MBA, FACP, to discuss MDS at the Eleventh Annual Meeting of SOHO.
Dr. Konopleva explains the controversy and what she sees on the horizon for MRD in AML.
Guillermo Garcia-Manero, MD, joins Chadi Nabhan, MD, MBA, FACP, to discuss the COMMANDS trial at the SOHO Annual Meeting.
Dr. Shadman rounds up the latest news on CLL from the summer conferences in this episode of The HemOnc Pulse.
The changes brought about by molecular characterization have a profound impact on real-world clinical care for AML.
Nitin Jain, MD, discusses the data on venetoclax combinations in CLL and key frontline treatment considerations.
Dr. Nowakowski discusses the L-MIND study and the "revolution in the treatment of DLBCL" in recent years.
Naveen Pemmaraju, MD, discusses the rare, ultrarare, and forgotten blood cancers on this episode of The HemOnc Pulse.
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.